Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated Radiotherapy With or Without Concurrent Cisplatin for Locoregionally Advanced Nasopharyngeal Carcinoma
The purpose of this study is to compare gemcitabine plus cisplatin induction chemotherapy
combine intensity-modulated radiotherapy with or without concurrent cisplatin in patients
with locoregionally advanced nasopharyngeal carcinoma (NPC), in order to reevaluate the
value of concurrent cisplatin when 4 cycles induction chemotherapy (gemcitabine+cisplatin)
and IMRT is used.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Overall survival is calculated from randomization to death from any cause.
yong Su, M.D.
Sun Yat-sen University
China: Ministry of Health